<bill session="116" type="hr" number="242" updated="2019-05-02T07:15:21Z">
  <state datetime="2019-03-18">REFERRED</state>
  <status>
    <introduced datetime="2019-03-18"/>
  </status>
  <introduced datetime="2019-03-18"/>
  <titles>
    <title type="official" as="introduced">Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.</title>
    <title type="display">Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.</title>
  </titles>
  <sponsor bioguide_id="B001251"/>
  <cosponsors>
    <cosponsor bioguide_id="B001257" joined="2019-03-18"/>
    <cosponsor bioguide_id="F000461" joined="2019-05-01"/>
  </cosponsors>
  <actions>
    <action datetime="2019-03-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-03-18" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Congressional tributes"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Health care quality"/>
    <term name="Health promotion and preventive care"/>
    <term name="Medical research"/>
    <term name="Prescription drugs"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
